Malarial Drug Delivery Systems 2023
DOI: 10.1007/978-3-031-15848-3_4
|View full text |Cite
|
Sign up to set email alerts
|

Malaria – Current Treatment Options

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…Meanwhile, Quinine derivates are considered the firstline choice for non-P. falciparum infection. 12 Plasmodium parasites are now reported to be resistant to several ACT drugs due to mutations in the kelch13 gene reported in the Greater Mekong Subregion (GMS). 13,14 Resistance is also experienced by vectors of malaria and Anopheles mosquitoes against insecticides (ITN/IRS) due to mutations of the L1014S gene.…”
Section: Introductionmentioning
confidence: 99%
“…Meanwhile, Quinine derivates are considered the firstline choice for non-P. falciparum infection. 12 Plasmodium parasites are now reported to be resistant to several ACT drugs due to mutations in the kelch13 gene reported in the Greater Mekong Subregion (GMS). 13,14 Resistance is also experienced by vectors of malaria and Anopheles mosquitoes against insecticides (ITN/IRS) due to mutations of the L1014S gene.…”
Section: Introductionmentioning
confidence: 99%